Quotient Sciences today announces the successful initiation of a clinical study evaluating a novel drug product developed ...

Sapu Nano and Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) today announced that Vuong Trieu, Chief Executive Officer, will present the Company’s Deciparticle™ nanomedicine platform at ...

Artificial intelligence is shifting formulation development from empirical trial-and-error to predictive, data-driven design ...

Clinical evaluation of several modified release once-daily formulations of danuglipron resulted in encouraging pharmacokinetic data for several candidates with one showing the most favorable profile ...

In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...

The aim of any formulation scientist is to create a product that is safe, effective, stable, and distinct from competitor drugs. It also helps if the product is as patient friendly as possible to ...

eTheRNA Manufacturing, a specialist CDMO member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and ...

Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...

Stay ahead in the rapidly evolving LNP space with the 4 th LNP Formulation & Process Development Summit - the largest global meeting dedicated purely to LNPs. The official event guide is your ...

Industry experts discuss the benefits of utilizing contract development and contract research organizations in drug discovery and development. Drug discovery can involve extensive research to identify ...